Shionogi will increase stake in Apnimed within 12 months of IPO
Resolves: Shionogi increases its equity stake in Apnimed by at least 5 percentage points (via direct purchase, secondary acquisition, or equity investment) within 12 months following the IPO pricing date.
user-generated· adoption
Shionogi will increase stake in Apnimed within 12 months of IPO
Market overview
Shionogi's strategic investment in Apnimed signals long-term commitment. Post-IPO, with Apnimed's capital infusion and clinical progress, Shionogi is likely to expand its ownership to maintain control and align incentives for commercialization.
adoption prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2027-07-10
About this prediction
Resolution criteria
Shionogi increases its equity stake in Apnimed by at least 5 percentage points (via direct purchase, secondary acquisition, or equity investment) within 12 months following the IPO pricing date.
Source: user-generated
More adoption markets
- Daily active crypto users surpass 100 million by mid-2026 — 60% Yes
- Kalshi’s market share in crypto derivatives surpasses 5% by Q4 2027 — 55% Yes
- Kalshi's crypto perpetual futures launch by 2026-Q4 — 75% Yes
- Family offices double down on crypto-adjacent mining firms within 6 months — 72% Yes
- Nigeria's crypto transaction volume exceeds $5B in 2026 — 80% Yes
- AI and crypto groups increase political ad spending in 2026 midterms — 80% Yes
- Crypto and AI groups double political ad spending by 2027 — 75% Yes
- Crypto billionaire Harborne will increase donations to Farage by 20% by Mar 2027 — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…